Mechanisms of Action of Dorsal Root Ganglion Stimulation for Chronic Pain
背根神经节刺激治疗慢性疼痛的作用机制
基本信息
- 批准号:10199761
- 负责人:
- 金额:$ 3.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAfferent NeuronsAlternative TherapiesAmericanAnalgesicsAnatomic ModelsAnatomyAutomobile DrivingBiological MarkersCellsCessation of lifeClinicalClinical DataClinical Decision Support SystemsComputer ModelsDataDiseaseDorsalElectrodesElectromyographyElectrophysiology (science)EnsureFDA approvedGangliaGoalsHealth Care CostsHistologicHistologyHumanImplantIndividualIntractable PainKnowledgeLeadLocationMagnetic Resonance ImagingMeasurementMeasuresMedicalMichiganModelingMuscleNeuronsOpioidOrthopedic SurgeryOutcomeOverdosePainPain MeasurementPaintParesthesiaPatient-Focused OutcomesPatientsPharmaceutical PreparationsPharmacologic SubstancePhysiologic pulsePhysiologicalPositioning AttributePostoperative PeriodPrevalenceProceduresPublic HealthRefractoryScanningSignal TransductionSocietiesSourceSpinal CordSpinal GangliaStimulusSubcellular AnatomySystemTechnologyTestingTherapeuticUnited StatesVariantVisualWidthX-Ray Computed Tomographyanalogbasebody mapchronic painclinical careclinical implementationclinical painconventional therapydesignexperimental studyfirst-in-humanhuman dataimplementation outcomesimprovedinsightinterpatient variabilityneurophysiologynew technologynovelopioid epidemicpain inhibitionpain reliefpredictive modelingrelating to nervous systemresponsetherapy outcometreatment optimization
项目摘要
Project Summary
The goal of this study is to elucidate the mechanisms of action of dorsal root ganglion stimulation
(DRGS) for chronic pain. Chronic pain affects approximately 100 million Americans, and accounts for more
than 600 billion dollars in healthcare costs each year. DRGS is an FDA-approved neurostimulation therapy for
chronic pain that is refractory to conventional medical management. Although some patients receive sufficient
pain relief in response to DRGS, clinical outcomes are often inconsistent. This variation in pain relief across
patients may be due to poor understanding of the physiological mechanisms governing stimulation-induced
pain relief. Therefore, we seek to uncover these mechanisms to ultimately optimize DRGS and improve clinical
outcomes. This study is driven by previous computer modeling results from our lab showing that within
stimulation parameter ranges used clinically, DRGS is likely driving the activity of large myelinated sensory
neurons. In this proposed study, we will further investigate these mechanisms using computational models to
determine sources of interpatient variability in DRGS outcomes. Furthermore, we will validate these models
using clinical electrophysiological data, and inform the cellular anatomy of our models using histological data.
We hypothesize that electrode location will be the largest source of variability in DRGS outcomes, and that
positive DRGS outcomes will predict predominant activation of large myelinated sensory neurons. This project
aims to characterize the mechanisms of action of DRGS to improve the implementation and outcomes of the
therapy, and the models resulting from this project could be used to systematically design and test novel
stimulation technologies (e.g. electrode and waveform design).
项目概要
本研究的目的是阐明背根神经节刺激的作用机制
(DRGS) 用于慢性疼痛。慢性疼痛影响着大约 1 亿美国人,并导致更多
每年的医疗费用超过 6000 亿美元。 DRGS 是 FDA 批准的一种神经刺激疗法
传统医疗治疗难以治愈的慢性疼痛。尽管有些患者接受了足够的治疗
DRGS 的疼痛缓解效果,临床结果往往不一致。这种疼痛缓解的差异
患者可能是由于对控制刺激引起的生理机制了解甚少
缓解疼痛。因此,我们寻求揭示这些机制,以最终优化 DRGS 并改善临床
结果。这项研究是由我们实验室之前的计算机建模结果驱动的,显示在
根据临床使用的刺激参数范围,DRGS 可能驱动大有髓感觉的活动
神经元。在这项拟议的研究中,我们将使用计算模型进一步研究这些机制
确定 DRGS 结果中患者间变异的来源。此外,我们将验证这些模型
使用临床电生理学数据,并使用组织学数据了解我们模型的细胞解剖学。
我们假设电极位置将是 DRGS 结果变异的最大来源,并且
阳性 DRGS 结果将预测大有髓感觉神经元的主要激活。本项目
旨在描述 DRGS 的行动机制,以改善 DRGS 的实施和成果
疗法,该项目产生的模型可用于系统地设计和测试新颖的
刺激技术(例如电极和波形设计)。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dorsal Root Ganglion Stimulation for Chronic Pain: Hypothesized Mechanisms of Action.
- DOI:10.1016/j.jpain.2021.07.008
- 发表时间:2022-03
- 期刊:
- 影响因子:0
- 作者:Graham RD;Sankarasubramanian V;Lempka SF
- 通讯作者:Lempka SF
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Dwight Graham其他文献
Robert Dwight Graham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
面向类脑智能感知的编码运算一体化柔性电子传入神经元的研究
- 批准号:
- 批准年份:2021
- 资助金额:60 万元
- 项目类别:面上项目
不同刺灸法激活的穴位传入神经元及时间-空间反应特性
- 批准号:81973967
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
有髓传入神经纤维相应DRG神经元中Cav3.2通道N-糖基化在DPN触诱发痛发生发展中的作用机制研究
- 批准号:81801219
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
通过内皮素-1探索初级传入神经元感受疼痛或搔痒的细胞机制
- 批准号:81171040
- 批准年份:2011
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Novel 5-HT7 Antagonists for the Treatment of Pruritus
用于治疗瘙痒的新型 5-HT7 拮抗剂
- 批准号:
10547410 - 财政年份:2022
- 资助金额:
$ 3.12万 - 项目类别:
The effects of Ojeok-san on neuro-immune interactions in cancer-induced visceral pain
Ojeok-san 对癌症引起的内脏疼痛中神经免疫相互作用的影响
- 批准号:
10004566 - 财政年份:2019
- 资助金额:
$ 3.12万 - 项目类别:
CRCNS: Towards Pain Control: Synergizing Computational and Biological Approaches
CRCNS:迈向疼痛控制:协同计算和生物学方法
- 批准号:
9323301 - 财政年份:2016
- 资助金额:
$ 3.12万 - 项目类别:
CRCNS: Towards Pain Control: Synergizing Computational and Biological Approaches
CRCNS:迈向疼痛控制:协同计算和生物学方法
- 批准号:
9242340 - 财政年份:2016
- 资助金额:
$ 3.12万 - 项目类别:
The effects of organophosphates on anxiety-related behavior and neurodevelopment
有机磷酸酯对焦虑相关行为和神经发育的影响
- 批准号:
8712483 - 财政年份:2012
- 资助金额:
$ 3.12万 - 项目类别: